New hope for tough prostate cancer: first human trial launches
Disease control
Recruiting now
This early-stage trial tests a new drug called [225Ac]Ac-FL-020 in 50 people with a hard-to-treat type of prostate cancer that has spread and stopped responding to hormone therapy. The main goals are to check the drug's safety and find the right dose. The drug works by targeting …
Phase: PHASE1 • Sponsor: Full-Life Technologies GmbH • Aim: Disease control
Last updated May 13, 2026 16:00 UTC